Vanguard Group’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.15M	Sell	419,613 -246,941	-37%	-$3.03M	﹤0.01%	3209
2025 Q1	$7.34M	Buy	+666,554	New	+$7.34M	﹤0.01%	3017